Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up

Publication: Blood Cancer Journal
UBC Author(s): Kerry Savage (Division of Medical Oncology / Faculty of Medicine)
Volume: 15
Publication Date: December 2025